Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03103100 · ClinicalTrials.gov registry record · Phase 3
Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation
A Phase 3 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 3
- Development phase
- 75
- Enrollment target
NCT03103100 is a Phase 3 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 75 participants.
The verdict
NCT03103100, a Phase 3 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 75 participants
- Enrollment target
Study Summary
This study will compare and determine the most ideal local anesthetic (LA) solution to activate a labor epidural: lidocaine, bupivacaine, or a combination of bupivacaine plus lidocaine.
Interventions
- DRUG 0.25% Bupivacaine
- DRUG 1% Lidocaine
- DRUG Bupivacaine plus Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2015-10-08 |
| Est. Completion | 2019-09-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03103100
The ClinicalTrials.gov registry entry for NCT03103100 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 0.25% Bupivacaine is the first listed.
NCT03103100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03103100 about?
NCT03103100 is a clinical study titled "Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation". This study will compare and determine the most ideal local anesthetic (LA) solution to activate a labor epidural: lidocaine, bupivacaine, or a combination of bupivacaine plus lidocaine.
What is the current status of trial NCT03103100?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 75 participants. The study started on 2015-10-08. Estimated completion is 2019-09-09.
What interventions are being tested in trial NCT03103100?
The interventions under investigation include: 0.25% Bupivacaine (DRUG), 1% Lidocaine (DRUG), Bupivacaine plus Lidocaine (DRUG).
Who is sponsoring clinical trial NCT03103100?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.